Pictor Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 11

Pictor General Information

Description

Developer of a proteomics platform designed to detect multiple biomarkers simultaneously for comprehensive biological analysis. The company offers an AI-integrated, end-to-end workflow, enabling clinical trials, diagnostics manufacturers, clinical labs, drug developers, and veterinary clinics to gain broader insights with reduced cost and complexity

Contact Information

Website
www.pictorproteomics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5315 Avenida Encinas
  • Suite 120
  • Carlsbad, CA 92008
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 5315 Avenida Encinas
  • Suite 120
  • Carlsbad, CA 92008
  • United States
+1 (800)

Pictor Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pictor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series A) $1.5M Upcoming Generating Revenue
12. Later Stage VC 30-Jun-2026 Completed Generating Revenue
11. Later Stage VC 23-Sep-2025 Completed Generating Revenue
10. Later Stage VC 04-Dec-2022 Completed Product Development
9. Later Stage VC 14-Apr-2022 Completed Product Development
8. Later Stage VC 01-Jan-2021 Completed Product Development
7. Grant 02-Sep-2020 Completed Product Development
6. Grant 02-Jul-2020 Completed Product Development
5. Grant 01-Nov-2012 $5.24K $2.14M Completed Product Development
4. Later Stage VC $1.6M $2.14M Completed Product Development
To view Pictor’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Pictor Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a proteomics platform designed to detect multiple biomarkers simultaneously for comprehensive biological an
Diagnostic Equipment
Carlsbad, CA
25 As of 2025

Lubeck, Germany
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pictor Competitors (4)

One of Pictor’s 4 competitors is Euroimmun Medizinische Labordiagnostika, a Formerly PE-Backed company based in Lubeck, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Euroimmun Medizinische Labordiagnostika Formerly PE-Backed Lubeck, Germany
Roche Corporation Basel, Switzerland
Zoetis Corporation Parsippany, NJ
Idexx Diagnostic Corporation Dublin, Ireland
To view Pictor’s complete competitors history, request access »

Pictor Patents

  • 30

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Pictor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026043886-A1 Systems and methods of analyte detection Pending 20-Aug-2024
AU-2022252931-A1 Multiplex immunoassay for the detection of mycoplasma bovis infection Pending 09-Apr-2021
AU-2022252931-A9 Multiplex immunoassay for the detection of mycoplasma bovis infection Pending 09-Apr-2021
EP-4320438-A1 Multiplex immunoassay for the detection of mycoplasma bovis infection Pending 09-Apr-2021
EP-4320438-A4 Multiplex immunoassay for the detection of mycoplasma bovis infection Pending 09-Apr-2021 G01N33/56933
To view Pictor’s complete patent history, request access »

Pictor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pictor Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Coddle Creek Capital Venture Capital Minority
Massey Ventures Venture Capital Minority
Arc Angels Angel Group Minority
Angel (individual) Minority
New Zealand Growth Capital Partners Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Pictor FAQs

  • When was Pictor founded?

    Pictor was founded in 2005.

  • Where is Pictor headquartered?

    Pictor is headquartered in Carlsbad, CA.

  • What is the size of Pictor?

    Pictor has 25 total employees.

  • What industry is Pictor in?

    Pictor’s primary industry is Diagnostic Equipment.

  • Is Pictor a private or public company?

    Pictor is a Private company.

  • What is Pictor’s current revenue?

    The current revenue for Pictor is .

  • How much funding has Pictor raised over time?

    Pictor has raised $35.9M.

  • Who are Pictor’s investors?

    Coddle Creek Capital, Massey Ventures, Arc Angels, , and New Zealand Growth Capital Partners are 5 of 11 investors who have invested in Pictor.

  • Who are Pictor’s competitors?

    Euroimmun Medizinische Labordiagnostika, Roche, Zoetis, and Idexx Diagnostic are competitors of Pictor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process